Jump to content

Eric Verdin

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 07:19, 11 January 2021 (Add: s2cid, bibcode, author pars. 1-1. Removed parameters. Some additions/deletions were actually parameter name changes. | You can use this bot yourself. Report bugs here. | Suggested by Abductive | Category:University of California, San Francisco faculty | via #UCB_Category 243/264). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Eric M. Verdin is the 5th President and Chief Executive Officer of the Buck Institute for Research on Aging.[1][2] He is a native of Belgium. Dr. Verdin is also a Professor of Medicine at University of California, San Francisco.[3]

Selected publications

Verdin has an h-index of 103.[4]

  • Verdin, Eric (2015-12-04). "NAD+ in aging, metabolism, and neurodegeneration". Science. 350 (6265): 1208–1213. Bibcode:2015Sci...350.1208V. doi:10.1126/science.aac4854. ISSN 0036-8075. PMID 26785480. S2CID 27313960.
  • Verdin, Eric; Ott, Melanie (2015). "50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond". Nature Reviews Molecular Cell Biology. 16 (4): 258–264. doi:10.1038/nrm3931. ISSN 1471-0080. PMID 25549891. S2CID 10192177.
  • Gut, Philipp; Verdin, Eric (2013-10-24). "The nexus of chromatin regulation and intermediary metabolism". Nature. 502 (7472): 489–498. Bibcode:2013Natur.502..489G. doi:10.1038/nature12752. ISSN 1476-4687. PMID 24153302. S2CID 4471359.
  • Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Le Moan, Natacha; Grueter, Carrie A.; Lim, Hyungwook; Saunders, Laura R. (2013-01-11). "Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor". Science. 339 (6116): 211–214. Bibcode:2013Sci...339..211S. doi:10.1126/science.1227166. ISSN 0036-8075. PMC 3735349. PMID 23223453.
  • Hirschey, Matthew D.; Shimazu, Tadahiro; Jing, Enxuan; Grueter, Carrie A.; Collins, Amy M.; Aouizerat, Bradley; Stančáková, Alena; Goetzman, Eric; Lam, Maggie M. (2011-10-21). "SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome". Molecular Cell. 44 (2): 177–190. doi:10.1016/j.molcel.2011.07.019. ISSN 1097-4164. PMC 3563434. PMID 21856199.
  • Hirschey, Matthew D.; Shimazu, Tadahiro; Goetzman, Eric; Jing, Enxuan; Schwer, Bjoern; Lombard, David B.; Grueter, Carrie A.; Harris, Charles; Biddinger, Sudha (2010-03-04). "SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation". Nature. 464 (7285): 121–125. Bibcode:2010Natur.464..121H. doi:10.1038/nature08778. ISSN 1476-4687. PMC 2841477. PMID 20203611.

References

  1. ^ "Buck Institute for Research on Aging names new CEO, announces $10M board donation". Retrieved 2017-03-06.
  2. ^ "Novato's Buck Institute hires new CEO, gets $10M gift". The North Bay Business Journal. 2016-11-25. Retrieved 2017-03-06.
  3. ^ Dunn, James (2 January 2017). "The Buck's new CEO tackles aging". The North Bay Business Journal.
  4. ^ "Eric Verdin – Google Scholar Citations". scholar.google.com.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Eric_Verdin&oldid=999653194"